 Seven abstracts emphasize Jazzs leadership in neuroscience and commitment to ongoing innovation DUBLIN , Sept. 15, 2022 PRNewswire -- Jazz Pharmaceuticals plc Nasdaq: JAZZ today announced that the Company will present seven abstracts from across its neuroscience portfolio at the 35th annual Psych Congress 2022, being held September 17-20, 2022. 